Vaccine companies develop biological products that train the immune system to recognise and respond to infectious agents, cancer-associated targets and other disease-related antigens. Their work spans human health, veterinary medicine and preparedness for emerging pathogens.
This category includes companies working on:
Browse 69 UK vaccine companies below.
Biological medicines and vaccine manufacturing at Porton Down
Porton Biopharma is a government-owned biopharmaceutical company based at Porton Down, Wiltshire. It developed and manufactured biological medicines using microbial fermentation, including the UK's anthrax vaccine and Erwinase (crisantaspase), an enzyme therapy for acute lymphoblastic leukaemia. In March 2025, the…
Oral thermostable vaccine platform for infectious diseases
iosBio is a biotechnology company developing thermostable oral vaccines using adenoviral vector delivery. Its platform protects vaccine vectors to survive stomach transit and release in the lower small intestine, inducing mucosal and systemic immunity without cold chain requirements or needle administration. The lead…
Yeast strain engineering platform for recombinant protein biomanufacturing
Phenotypeca is a synthetic biology company that engineers baker's yeast strains for the production of recombinant proteins, biosimilars, and vaccine antigens. Using proprietary quantitative trait loci technology, the company generates and screens large libraries of yeast variants to identify production strains with…
Therapeutic cancer vaccines based on recombinant overlapping peptide technology
Oxford Vacmedix is a clinical-stage biopharma company developing therapeutic cancer vaccines using its proprietary Recombinant Overlapping Peptide (ROP) platform. ROPs stimulate broad T cell and antibody immunity without HLA restriction, enabling a universal immunotherapy approach. The lead programme, OVM-200, targets…
World leading centre researching viral diseases of farm animals
The Pirbright Institute researches viral diseases of farm animals and viruses that spread from animals to humans. The Institute works to predict, detect and respond to livestock diseases, developing vaccines and diagnostic tests that support global food security and public health. Its high containment laboratories…
Veterinary vaccine CDMO and aquaculture diagnostics for animal health
Marinnovac UK is a contract research and manufacturing organisation specialising in veterinary vaccine development and viral antigen production for animal and aquaculture health applications. The company holds the only VMD-approved viral autogenous vaccine manufacturing licence in the UK, offering services spanning…
Immunological reagents, assay services and target-binding proteins for immune research
ProImmune is a provider of immunological reagents and assay services supporting research into adaptive immune responses. The company offers assay services to help researchers understand immune responses to vaccines and therapeutics, using ELISpot and flow cytometry techniques, alongside recombinant target-binding…
UK affiliate of global innovative medicines company Novartis AG
Novartis Pharmaceuticals UK Limited is the UK commercial and medical affiliate of Novartis AG, the Swiss-headquartered global pharmaceutical company. Headquartered at White City Place in London, the UK operation employs approximately 1,300 people and focuses on commercialisation, medical affairs, regulatory…
Synthetic T cell-priming vaccines and immunotherapies for infectious disease
Gylden Pharma is a clinical-stage biotechnology company developing 100% synthetic T cell-priming vaccines and immunotherapies. Its nanoparticle platform delivers synthetic peptides that stimulate cellular immune responses against intracellular pathogens, providing strain-agnostic protection without cold-chain…
Engineered bacterial immunotherapies for solid tumours
Prokarium is a clinical-stage biopharmaceutical company developing microbial immunotherapies using engineered Salmonella strains. Its platform combines synthetic biology with AI-enabled discovery to create programmable bacterial therapeutics that deliver payloads within the tumour microenvironment. The lead programme…
Veterinary vaccine R&D and licensing for livestock infectious diseases
Cambivac develops and licenses veterinary vaccine technologies, combining genomic research with traditional virology and molecular approaches. Its documented development programmes include vaccines for foot-and-mouth disease and porcine reproductive and respiratory syndrome, a respiratory disease affecting pigs. The…
Sterile injectable drug manufacturing and fill-finish for global pharma
Patheon is a contract development and manufacturing site operating as part of Thermo Fisher Scientific's Pharma Services business. The site specialises in sterile liquid and freeze-dried injectable products, including high potency medicines and large volume parenterals, offering development, commercial manufacturing,…
Virus-like particle therapeutics for chronic inflammatory skin conditions
Glen Clova Scientific is a biotechnology company developing active biologic drugs for chronic inflammatory and autoimmune disorders, with an initial focus on immuno-dermatology. Its proprietary virus-like particle platform is designed to induce targeted immune responses against self-produced proteins that drive…
AI platform designing vaccines against current and future pathogens
Baseimmune is a biotechnology company developing a deep learning platform for computational vaccine antigen design. The platform integrates genomic, epidemiological, immunological, and evolutionary data to generate novel synthetic antigens drawn from across an entire pathogen genome, enabling the design of vaccines…
Inorganic nanoscale immune modulators for infection, cancer and autoimmunity
Iuvantium is a biotechnology company developing therapeutics and vaccines based on inorganic nanoscale materials that modulate the immune system. The company uses tailored inorganic probes to study how the immune system responds, builds a computational model of immune behaviour, and designs programmable immune…
Oral microbiome therapeutics for gastrointestinal and hepatic disease
EnteroBiotix is a clinical-stage biopharmaceutical company developing orally delivered, full-spectrum microbiome therapeutics for diseases linked to gut microbiome disruption. Its lead asset EBX-102-02 demonstrated clinically meaningful improvements in irritable bowel syndrome in Phase 2a trials, with a Phase 2b study…
Needle-free solid dose vaccine formulation and delivery platform
aVaxMed Limited is a UK biotech developing the aVaxziPen platform, a proprietary needle-free, thermally stable, solid dose vaccine delivery system. The technology encapsulates vaccine antigens into unit solid doses administered via a pen applicator, removing the need for needles and reducing cold chain requirements.…
Global biologics CDMO for vaccines, antibodies, and advanced therapies
FUJIFILM Biotechnologies is a contract development and manufacturing organisation providing process development and cGMP manufacturing of biologics, vaccines, and cell and gene therapies. Its UK site at Billingham, Teesside, includes mammalian cell culture and microbial fermentation facilities, with the UK's largest…
T cell immune monitoring products and immunology contract research
ImmunoServ is a Welsh contract research and diagnostics company specialising in T cell immunology and cancer immunotherapy. The company develops and supplies standardised T cell testing kits that measure antigen-specific cellular immune responses from blood samples, with applications in infectious disease…
Oncology drug discovery and IP licensing from rural Wales
Morvus Technology is a privately owned pharmaceutical company engaged in the discovery, development, and out-licensing of novel oncology drugs and platform technologies. The company's portfolio includes ProTide nucleoside chemistry, out-licensed to NuCana plc for clinical development; an inhaled anti-tumour agent for…